Funding

>

Latest News

The NIH’s Role in New Drug Development
The NIH’s Role in New Drug Development

March 7th 2025

Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.

Eikon Therapeutics Raises $350 Million in Series D Funding to Advance Oncology Pipeline
Eikon Therapeutics Raises $350 Million in Series D Funding to Advance Oncology Pipeline

February 26th 2025

Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO
Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO

February 20th 2025

Applyo Jena Closes Successful Series A Funding Round
Applyo Jena Closes Successful Series A Funding Round

February 19th 2025

Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans
Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans

February 14th 2025

More News